These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 14624703)

  • 1. Baclofen for maintenance treatment of opioid dependence: a randomized double-blind placebo-controlled clinical trial [ISRCTN32121581].
    Assadi SM; Radgoodarzi R; Ahmadi-Abhari SA
    BMC Psychiatry; 2003 Nov; 3():16. PubMed ID: 14624703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baclofen as add-on to standard psychosocial treatment for alcohol dependence: a randomized, double-blind, placebo-controlled trial with 1 year follow-up.
    Ponizovsky AM; Rosca P; Aronovich E; Weizman A; Grinshpoon A
    J Subst Abuse Treat; 2015 May; 52():24-30. PubMed ID: 25572706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double-blind randomized controlled trial of baclofen vs. clonidine in the treatment of opiates withdrawal.
    Akhondzadeh S; Ahmadi-Abhari SA; Assadi SM; Shabestari OL; Kashani AR; Farzanehgan ZM
    J Clin Pharm Ther; 2000 Oct; 25(5):347-53. PubMed ID: 11123486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Double blind placebo controlled randomized pilot clinical trial of baclofen (Baclosan®) for alcohol dependence].
    Krupitsky EM; Rybakova KV; Kiselev AS; Alexeeva YV; Berntsev VA; Chekhlaty EI; Zubova EY; Popov YV; Neznanov NG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(6):53-62. PubMed ID: 26356398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of baclofen for alcohol dependence: a randomized, double-blind, placebo-controlled trial.
    Garbutt JC; Kampov-Polevoy AB; Gallop R; Kalka-Juhl L; Flannery BA
    Alcohol Clin Exp Res; 2010 Nov; 34(11):1849-57. PubMed ID: 20662805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomized placebo-controlled trial of baclofen for cocaine dependence: preliminary effects for individuals with chronic patterns of cocaine use.
    Shoptaw S; Yang X; Rotheram-Fuller EJ; Hsieh YC; Kintaudi PC; Charuvastra VC; Ling W
    J Clin Psychiatry; 2003 Dec; 64(12):1440-8. PubMed ID: 14728105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Baclofen versus clonidine in the treatment of opiates withdrawal, side-effects aspect: a double-blind randomized controlled trial.
    Ahmadi-Abhari SA; Akhondzadeh S; Assadi SM; Shabestari OL; Farzanehgan ZM; Kamlipour A
    J Clin Pharm Ther; 2001 Feb; 26(1):67-71. PubMed ID: 11286609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treating alcohol withdrawal with oral baclofen: a randomized, double-blind, placebo-controlled trial.
    Lyon JE; Khan RA; Gessert CE; Larson PM; Renier CM
    J Hosp Med; 2011 Oct; 6(8):469-74. PubMed ID: 21990176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study.
    Addolorato G; Caputo F; Capristo E; Domenicali M; Bernardi M; Janiri L; Agabio R; Colombo G; Gessa GL; Gasbarrini G
    Alcohol Alcohol; 2002; 37(5):504-8. PubMed ID: 12217947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lofexidine versus diazepam for the treatment of opioid withdrawal syndrome: A double-blind randomized clinical trial in Singapore.
    Guo S; Manning V; Yang Y; Koh PK; Chan E; de Souza NN; Assam PN; Sultana R; Wijesinghe R; Pangjaya J; Kandasami G; Cheok C; Lee KM; Wong KE
    J Subst Abuse Treat; 2018 Aug; 91():1-11. PubMed ID: 29910009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of GABA(B) receptor in alcohol dependence: reducing effect of baclofen on alcohol intake and alcohol motivational properties in rats and amelioration of alcohol withdrawal syndrome and alcohol craving in human alcoholics.
    Colombo G; Addolorato G; Agabio R; Carai MA; Pibiri F; Serra S; Vacca G; Gessa GL
    Neurotox Res; 2004; 6(5):403-14. PubMed ID: 15545024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetrodotoxin alleviates acute heroin withdrawal syndrome: a multicentre, randomized, double-blind, placebo-controlled study.
    Song H; Li J; Lu CL; Kang L; Xie L; Zhang YY; Zhou XB; Zhong S
    Clin Exp Pharmacol Physiol; 2011 Aug; 38(8):510-4. PubMed ID: 21575032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pexacerfont as a CRF1 antagonist for the treatment of withdrawal symptoms in men with heroin/methamphetamine dependence: a randomized, double-blind, placebo-controlled clinical trial.
    Morabbi MJ; Razaghi E; Moazen-Zadeh E; Safi-Aghdam H; Zarrindast MR; Vousoghi N; Akhondzadeh S
    Int Clin Psychopharmacol; 2018 Mar; 33(2):111-119. PubMed ID: 29064909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of high-dose baclofen for the treatment of alcohol dependence: A multicentre, randomised, double-blind controlled trial.
    Beraha EM; Salemink E; Goudriaan AE; Bakker A; de Jong D; Smits N; Zwart JW; Geest DV; Bodewits P; Schiphof T; Defourny H; van Tricht M; van den Brink W; Wiers RW
    Eur Neuropsychopharmacol; 2016 Dec; 26(12):1950-1959. PubMed ID: 27842939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hab-o Shefa, a Persian Medicine Compound for Maintenance Treatment of Opioid Dependence: Randomized Placebo-Controlled Clinical Trial.
    Moosavyzadeh A; Mokri A; Ghaffari F; Faghihzadeh S; Azizi H; Jafari Hajati R; Naseri M
    J Altern Complement Med; 2020 May; 26(5):376-383. PubMed ID: 32109133
    [No Abstract]   [Full Text] [Related]  

  • 16. Ability of baclofen in reducing alcohol craving and intake: II--Preliminary clinical evidence.
    Addolorato G; Caputo F; Capristo E; Colombo G; Gessa GL; Gasbarrini G
    Alcohol Clin Exp Res; 2000 Jan; 24(1):67-71. PubMed ID: 10656195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase III, randomized, multi-center, double blind, placebo controlled study of safety and efficacy of lofexidine for relief of symptoms in individuals undergoing inpatient opioid withdrawal.
    Gorodetzky CW; Walsh SL; Martin PR; Saxon AJ; Gullo KL; Biswas K
    Drug Alcohol Depend; 2017 Jul; 176():79-88. PubMed ID: 28527421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of pharmacological treatments for opioid-dependent adolescents: a randomized controlled trial.
    Marsch LA; Bickel WK; Badger GJ; Stothart ME; Quesnel KJ; Stanger C; Brooklyn J
    Arch Gen Psychiatry; 2005 Oct; 62(10):1157-64. PubMed ID: 16203961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FORWARDS-1: an adaptive, single-blind, placebo-controlled ascending dose study of acute baclofen on safety parameters in opioid dependence during methadone-maintenance treatment-a pharmacokinetic-pharmacodynamic study.
    Paterson LM; Barker D; Cro S; Mozgunov P; Phillips R; Smith C; Nahar L; Paterson S; Lingford-Hughes AR
    Trials; 2022 Oct; 23(1):880. PubMed ID: 36258248
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial.
    Krupitsky E; Nunes EV; Ling W; Illeperuma A; Gastfriend DR; Silverman BL
    Lancet; 2011 Apr; 377(9776):1506-13. PubMed ID: 21529928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.